ADVANCED THERAPY AND PERSONALISED MEDICINE.

Area 3 is made up of 8 research lines and 18 research groups. Among their general objectives are the identification of biomarkers that allow prognosis and/or treatment response to be predicted when treating inflammatory, infectious or tumour-based diseases; optimisation of biological treatments through identification of biomarkers that predict treatment response; the identification of new drugs and/or treatment targets; and the search for new treatment and improvements in treatment efficacy and safety and managing its effects on patient quality of life.